Pacer Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-105,431
| Closed | -$1.54M | – | 1437 |
|
|
2021
Q1 | $1.54M | Buy |
105,431
+78,830
| +296% | +$1.15M | 0.03% | 598 |
|
|
2020
Q4 | $462K | Buy |
26,601
+5,472
| +26% | +$95K | 0.01% | 1002 |
|
|
2020
Q3 | $388K | Buy |
21,129
+11,339
| +116% | +$208K | 0.01% | 1066 |
|
|
2020
Q2 | $175K | Buy |
+9,790
| New | +$175K | ﹤0.01% | 815 |
|
|
2018
Q4 | – | Sell |
-4,767
| Closed | -$79K | – | 628 |
|
|
2018
Q3 | $79K | Buy |
+4,767
| New | +$79K | ﹤0.01% | 1113 |
|
|
2018
Q1 | – | Sell |
-1,725
| Closed | -$15K | – | 1053 |
|
|
2017
Q4 | $15K | Buy |
+1,725
| New | +$15K | ﹤0.01% | 1117 |
|